These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6151207)

  • 21. Differential suppression of intracranial self-stimulation, food-maintained operant responding, and open field activity by paw incision and spinal nerve ligation in rats.
    Ewan EE; Martin TJ
    Anesth Analg; 2014 Apr; 118(4):854-62. PubMed ID: 24651240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonism of the antidepressant-like effects of clenbuterol by central administration of beta-adrenergic antagonists in rats.
    Zhang HT; Huang Y; O'Donnell JM
    Psychopharmacology (Berl); 2003 Oct; 170(1):102-7. PubMed ID: 12898120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of antidepressants in rats trained to discriminate the beta-2 adrenergic agonist clenbuterol.
    Makhay MM; O'Donnell JM
    Pharmacol Biochem Behav; 1999 Jun; 63(2):319-24. PubMed ID: 10371662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-adrenergic agonists reduce spontaneous motor activity through either beta 1 or beta 2 receptors.
    Frances H; Renwart N; Danti S; Cash R; Raisman R; Simon P
    Pharmacol Biochem Behav; 1987 Jan; 26(1):11-5. PubMed ID: 2882523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between beta-adrenoceptor agonists and alpha 1-adrenergic system. A behavioral study with the clonidine-induced aggression test.
    Mogilnicka E; Zazula M
    Pol J Pharmacol Pharm; 1986; 38(5-6):529-34. PubMed ID: 2883639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of clenbuterol and prenalterol on behavior maintained under a multiple fixed-interval, fixed-ratio schedule.
    O'Donnell JM
    J Pharmacol Exp Ther; 1987 Aug; 242(2):588-94. PubMed ID: 2886645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of beta-agonists on normal and clonidine-decelerated noradrenaline turnover in the rat brain.
    Nowak G; Mogilnicka E
    Pol J Pharmacol Pharm; 1985; 37(6):765-72. PubMed ID: 2870484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of clenbuterol and salbutamol on tissue rubidium uptake in vivo.
    Cartañà J; Stock MJ
    Metabolism; 1995 Jan; 44(1):119-25. PubMed ID: 7854156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clenbuterol, a central beta-adrenoceptor agonist.
    Hall H; Sällemark M; Ross SB
    Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):159-60. PubMed ID: 6108047
    [No Abstract]   [Full Text] [Related]  

  • 31. Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology.
    Liebman JM
    Neurosci Biobehav Rev; 1983; 7(1):45-72. PubMed ID: 6132357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1976; 26(7a):1404-20. PubMed ID: 12768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation.
    Izeboud CA; Hoebe KH; Grootendorst AF; Nijmeijer SM; van Miert AS; Witkamp RR; Rodenburg RJ
    Inflamm Res; 2004 Mar; 53(3):93-9. PubMed ID: 15021963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats.
    Lazenka MF; Blough BE; Negus SS
    J Sex Med; 2016 Mar; 13(3):338-49. PubMed ID: 26831817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of beta 2-adrenoceptor agonists on serotonin biochemistry and function.
    Green AR; Cowen PJ; Nimgaonkar VL; Grahame-Smith DG
    Adv Biochem Psychopharmacol; 1984; 39():285-8. PubMed ID: 6205560
    [No Abstract]   [Full Text] [Related]  

  • 36. Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: a role for IκB.
    Ryan KJ; Griffin É; Yssel JD; Ryan KM; McNamee EN; Harkin A; Connor TJ
    Neurochem Int; 2013 Nov; 63(5):368-78. PubMed ID: 23896303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of the discriminative stimulus effects of clenbuterol in rats.
    O'Donnell JM
    Pharmacol Biochem Behav; 1997 Nov; 58(3):813-8. PubMed ID: 9329076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evidence of the inhibitory role of perifornical hypothalamic beta-adrenergic receptors in the feeding behaviour of hungry rats.
    Bendotti C; Villa M; Samanin R
    Life Sci; 1986 Jan; 38(3):259-66. PubMed ID: 2867451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attempt at pharmacological differentiation of central beta-adrenergic receptors.
    Frances H; Puech AJ; Danti S; Simon P
    Eur J Pharmacol; 1983 Sep; 92(3-4):223-30. PubMed ID: 6138262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between beta 2- and alpha 2-adrenoceptor responses in the vascular system: effect of clenbuterol.
    Kazanietz MG; Gutkind JS; Enero MA
    Eur J Pharmacol; 1986 Oct; 130(1-2):119-24. PubMed ID: 3023111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.